Daniel Asher discloses 16.5% Ekso Bionics (EKSO) stake via trust and LLC

Rhea-AI Filing Summary

Ekso Bionics Holdings, Inc. received an amended ownership disclosure showing a significant shareholder position by Daniel Asher. He is reported as beneficial owner of 677,723 ordinary shares, representing 16.51% of the class, with shared voting and dispositive power.

The filing lists related reporting persons including Daniel Asher Descendants Trust, which holds 355,960 shares (8.67%), and DBA Trading, LLC, which holds 156,763 shares (3.82%). The signatories certify the shares are not held for the purpose of changing or influencing control of Ekso Bionics.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Ekso Bionics Holdings, Inc.

(Name of Issuer)

Ordinary Shares, nominal value $0.01 per share

(Title of Class of Securities)

282644400

(CUSIP Number)

01/22/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 282644400

1

Names of Reporting Persons

DANIEL ASHER

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 677,723.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 677,723.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

677,723.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

16.51 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 282644400

1

Names of Reporting Persons

Daniel Asher Descendants Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 355,960.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 355,960.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

355,960.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.67 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

CUSIP No. 282644400

1

Names of Reporting Persons

DBA Trading, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 156,763.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 156,763.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

156,763.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

3.82 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Ekso Bionics Holdings, Inc.
(b)	Address of issuer's principal executive offices: 101 Glacier Point, Suite A San Rafael, CA 94901
Item 2.
(a)	Name of person filing: Daniel Asher, DBA Trading, LLC. Daniel Asher Descendants Trust
(b)	Address or principal business office or, if none, residence: 1011 Lake Street Suite 311 Oak Park, IL 60301
(c)	Citizenship: USA
(d)	Title of class of securities: Ordinary Shares, nominal value $0.01 per share
(e)	CUSIP No.: 282644400
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See Row 9 of cover page for each reporting person.
(b)	Percent of class: See Row 11 of cover page for each reporting person
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See Row 5 of cover page for each reporting Person.
	(ii) Shared power to vote or to direct the vote: See Row 6 of cover page for each reporting Person.
	(iii) Sole power to dispose or to direct the disposition of: See Row 7 of cover page for each reporting Person.
	(iv) Shared power to dispose or to direct the disposition of: See Row 8 of cover page for each reporting Person. Daniel Asher is the beneficial owner of, DBA Trading, LLC, and is deemed to control and share voting and dispositive power over the shares held by them. Daniel Asher is the Grantor of Daniel Asher Descendants trust and is deemed to control share voting and dispositive power over the shares held by them.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

DANIEL ASHER

Signature:	/s/ Daniel Asher
Name/Title:	Daniel Asher
Date:	01/27/2026

Daniel Asher Descendants Trust

Signature:	/s/ Daniel Asher
Name/Title:	Grantor
Date:	01/27/2026

DBA Trading, LLC

Signature:	/s/ Fred Goldman
Name/Title:	Fred Goldman, Member
Date:	01/27/2026

Exhibit Information

99.1 Joint Filing Agreement of the Reporting Persons. 99.2 Transactions of the Reporting Persons

FAQ

What stake in Ekso Bionics (EKSO) does Daniel Asher report in this Schedule 13G/A?

Daniel Asher reports beneficial ownership of 677,723 Ekso Bionics ordinary shares, representing 16.51% of the class. The filing states he has shared voting and dispositive power over these shares through affiliated entities, reflecting a significant minority holding in the company.

How many Ekso Bionics shares does the Daniel Asher Descendants Trust hold?

The Daniel Asher Descendants Trust reports beneficial ownership of 355,960 Ekso Bionics ordinary shares, equal to 8.67% of the class. The filing notes Daniel Asher is the grantor and is deemed to control and share voting and dispositive power over the trust’s shares.

What is DBA Trading, LLC’s ownership in Ekso Bionics (EKSO)?

DBA Trading, LLC reports beneficial ownership of 156,763 Ekso Bionics ordinary shares, representing 3.82% of the class. The filing explains Daniel Asher is the beneficial owner of DBA Trading, LLC and shares voting and dispositive power over the shares it holds.

Are the Ekso Bionics shares held by Daniel Asher intended to influence control of the company?

The signatories certify the securities were not acquired and are not held to change or influence control of Ekso Bionics. They also state the holdings are not part of any transaction aimed at such control, other than activities solely connected with a nomination under Rule 14a-11.

What class of Ekso Bionics securities is covered and what is the CUSIP?

The filing covers Ekso Bionics ordinary shares with a nominal value of $0.01 per share, identified by CUSIP 282644400. This clearly specifies the exact security class and code associated with the reported beneficial ownership stakes in the Schedule 13G/A amendment.

What event date triggered this amended ownership filing for Ekso Bionics (EKSO)?

The Schedule 13G/A lists January 22, 2026 as the date of the event requiring the filing. This date anchors when the ownership information became relevant under SEC rules and led to the amended beneficial ownership disclosure for Ekso Bionics ordinary shares.